[HTML][HTML] Psoriasis as a systemic disease

U Mrowietz, F Lauffer, W Sondermann… - Deutsches …, 2024 - pmc.ncbi.nlm.nih.gov
Background Psoriasis was long regarded as an inflammatory disease limited to the skin.
Data from dermatologic, rheumatologic and cardiologic research now show it to be a …

[PDF][PDF] Risk factors for psoriatic arthritis development in psoriasis patients: Myths, pitfalls, and pearls

YS Patt, A Watad, I Giovannini… - Clin. Exp …, 2024 - clinexprheumatol.org
Psoriatic arthritis (PsA) predominantly emerges in individuals previously diagnosed with
psoriasis (PsO), offering a unique opportunity to study the transition from PsO to PsA. This …

Psoriasis Comorbidities and Their Treatment Impact

M Taliercio, M Lebwohl - Dermatologic Clinics, 2024 - derm.theclinics.com
Psoriasis, a disease defined by systemic inflammation causing characteristic skin lesions, is
closely associated with significant comorbidities that are often underrecognized. This article …

Causal associations between both psoriasis and psoriatic arthritis and multiple autoimmune diseases: a bidirectional two-sample Mendelian randomization study

K Duan, J Wang, S Chen, T Chen, J Wang… - Frontiers in …, 2024 - frontiersin.org
Background Numerous observational studies have identified associations between both
psoriasis (PsO) and psoriatic arthritis (PsA), and autoimmune diseases (AIDs); however, the …

[HTML][HTML] Ustekinumab demonstrates lower uveitis risk in moderate to severe psoriasis patients compared with tumor necrosis factor-α inhibitors

CH Bang, HJ Oh, YH Kim, J Jin-Hyung… - Acta Dermato …, 2024 - pmc.ncbi.nlm.nih.gov
METHODS We included patients with moderate to severe psoriasis who had a psoriasis
area and severity index score> 10, despite receiving conventional treatment for 3 months …

[引用][C] Bibliographie «hiver 2024»

B Cribier - Annales de Dermatologie et de Vénéréologie-FMC, 2024 - Elsevier